Skip to content

Bicara Therapeutics BCAX State income taxes – net of federal income tax benefit

State income taxes – net of federal income tax benefit at other companies

REX American Resources logo
REX American ResourcesREX
3.4%+0.2pp
Virtu Financial logo
Virtu FinancialVIRT
2.3%-0.1pp
The Bancorp logo
The BancorpTBBK
3.2%
ADMA Biologics logo
ADMA BiologicsADMA
2.1%
Rumble, Inc. logo
Rumble, Inc.RUM
-0.1%
ePlus logo
ePlusPLUS
5.7%+0.5pp

Other financials

Income statement

See full
Operating income-$60.2M-44.2%
Net income-$56.2M-52.6%
EPS (diluted)-$0.93-36.8%

Balance sheet

See full
Cash & equivalents$323.5M-30.0%
Total debt$1.4M+144%
Total equity$514.0M+12.0%
Total assets$553.6M+15.8%

Cash flow

See full
Operating cash flow-$37.5M-33.5%
CapEx$60.0K
Free cash flow-$37.6M-33.7%

Valuation

See full
Market cap$1.68B+81.4%

Returns & leverage

See full
Return on equity-32.3%
Debt / equity0.0×
Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes.

The official record: Bicara Therapeutics’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's state income taxes – net of federal income tax benefit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bicara Therapeutics's state income taxes – net of federal income tax benefit?
Bicara Therapeutics (BCAX) reported state income taxes – net of federal income tax benefit of -0.1% in Q4 2025.
What does state income taxes – net of federal income tax benefit mean?
This metric represents the impact of state and local income taxes on the effective tax rate, adjusted for the federal tax benefit associated with deducting state taxes. It highlights the net cost of operating in various state jurisdictions. This is useful for evaluating the tax-related geographic footprint of the business.